Who is sponsoring NCT04185324?

NCT04185324 is sponsored by Salus University.

What drugs are being tested in NCT04185324?

Interventions in NCT04185324: Standard zippering vest, Modified zippering vest.

What condition does NCT04185324 study?

NCT04185324 studies Typical Preschoolers Who Can Not Zipper.

Is NCT04185324 still recruiting?

NCT04185324 is currently completed. Last updated 31 March 2020.

Last reviewed 2020-03-31 · How we verify

NCT04185324

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of an Intervention to Teach Zippering: A Two-Group Control Study

Completed NA Last updated 31 March 2020

What this trial tests

NA trial testing Standard zippering vest in Typical Preschoolers Who Can Not Zipper in 28 participants. Completed in 30 January 2020.

Timeline

1 September 2019

Primary endpoint
30 January 2020

30 January 2020

Quick facts

Lead sponsor	Salus University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	28
Start date	1 September 2019
Primary completion	30 January 2020
Estimated completion	30 January 2020
Sites	1 location across United States

Drugs / interventions tested

Standard zippering vest
Modified zippering vest

Conditions studied

Typical Preschoolers Who Can Not Zipper — all drugs for Typical Preschoolers Who Can Not Zipper →

Sponsor

Salus University

Who can join

Adults 42 Months to 60 Months, any sex, with Typical Preschoolers Who Can Not Zipper. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Preschoolers are assigned to a control group or a comparison group to examine the efficacy of a new intervention to teach the skill of engaging and pulling up a zipper.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Salus University trials

Trials by the same sponsor.

NCT06848673 — Natural History of MTBI-related Convergence Insufficiency & Effectiveness of Vision Therapy for MTBI-related CI · Phase 2 · not yet recruiting
NCT07282691 — Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders · recruiting
NCT05825248 — Comparing Two Protocols to Improve Reflex Integration and Functional Performance · NA · unknown
NCT05242575 — The Influence of Immersive Virtual Field Trips on Academic Vocabulary · NA · completed
NCT03780205 — Bilateral and Unilateral Amblyopia Treatment Study · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04185324 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Salus University
Last refreshed: 31 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04185324.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing